5325312025-10-012025-12-315325312025-04-012025-12-315325312025-10-012025-12-31in-capmkt:OtherExpenses1Member5325312025-04-012025-12-31in-capmkt:OtherExpenses1Member5325312025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325312025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325312025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15325312025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532531STARNOTLISTEDINE939A01011Strides Pharma Science LimitedMain BoardEquity2025-04-012026-03-312026-01-302026-01-23INRMillionsQuarterlyThird quarterSingle segmentPharmaceutical2026-01-3010:45:002026-01-3012:35:00Not applicable2025-10-012025-12-31UnauditedConsolidated119464600001068620000130150800004597070000713770000-68143000022954400004337900005062300002662160000105270300002488050000-3299000024550600002764600009707000037353000002081530000000-31000020812200009880000021800200002021070000601500002109260000707600009217300001021.9321.920021.9321.922025-04-012025-12-31UnauditedConsolidated353521300001425850000367779800001150043000023409000003835200006818430000136966000014915200007452990000313574500005420530000-204380000521615000061265000014131000075396000004462190000000-980000044523900002431900004695580000429249000015990000045124800001831000009217300001046.5746.570046.5746.57Other Expenses2662160000Other Expenses7452990000Items that will not be reclassified to statement of profit and loss-54360000-54360000Items that will not be reclassified to statement of profit and loss107700000107700000-1380000027020000Items that may be reclassified to statement of profit and loss123940000123940000Items that may be reclassified to statement of profit and loss89100008910000-15420000-15360000098800000243190000